APOF | Apolipoprotein F | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC17A2 | Solute carrier family 17, member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CYP2C8 | Cytochrome P450, family 2, subfamily C, polypeptide 8 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
F7 | Coagulation factor VII (serum prothrombin conversion accelerator) | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2A13 | Cytochrome P450, family 2, subfamily A, polypeptide 13 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
GDF2 | Growth differentiation factor 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
UGT2B10 | UDP glucuronosyltransferase 2 family, polypeptide B10 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CCL16 | Chemokine (C-C motif) ligand 16 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
F13B | Coagulation factor XIII, B polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C8A | Complement component 8, alpha polypeptide | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A9 | Solute carrier family 22 (organic anion transporter), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
HPR | Haptoglobin-related protein | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ORM1 | Orosomucoid 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ITIH3 | Inter-alpha-trypsin inhibitor heavy chain 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FGF21 | Fibroblast growth factor 21 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
INHBC | Inhibin, beta C | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR1 | Complement factor H-related 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ITIH4 | Inter-alpha-trypsin inhibitor heavy chain family, member 4 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PON1 | Paraoxonase 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MAT1A | Methionine adenosyltransferase I, alpha | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
AGXT | Alanine-glyoxylate aminotransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PRAMEF10 | PRAME family member 10 | Predicted intracellular proteins
| | | | | Tissue enriched |
C8B | Complement component 8, beta polypeptide | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC38A4 | Solute carrier family 38, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
INHBE | Inhibin, beta E | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP7A1 | Cytochrome P450, family 7, subfamily A, polypeptide 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
KLKB1 | Kallikrein B, plasma (Fletcher factor) 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
LECT2 | Leukocyte cell-derived chemotaxin 2 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
SDS | Serine dehydratase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
VTN | Vitronectin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CPN1 | Carboxypeptidase N, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
LPA | Lipoprotein, Lp(a) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PLGLB1 | Plasminogen-like B1 | Predicted secreted proteins
| | | | | Tissue enriched |
RTP3 | Receptor (chemosensory) transporter protein 3 | Predicted membrane proteins
| | | | | Tissue enriched |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP26A1 | Cytochrome P450, family 26, subfamily A, polypeptide 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
SLC27A5 | Solute carrier family 27 (fatty acid transporter), member 5 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CPB2 | Carboxypeptidase B2 (plasma) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
HSD17B13 | Hydroxysteroid (17-beta) dehydrogenase 13 | Predicted intracellular proteins
| | | | | Tissue enriched |
FMO3 | Flavin containing monooxygenase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PGLYRP2 | Peptidoglycan recognition protein 2 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AMBP | Alpha-1-microglobulin/bikunin precursor | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANG | Angiogenin, ribonuclease, RNase A family, 5 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
UGT1A4 | UDP glucuronosyltransferase 1 family, polypeptide A4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |